Biotech

All Articles

2 cancer biotechs combine, producing worldwide impact

.OncoC4 is taking AcroImmune-- and its internal scientific production capabilities-- under its fly a...

Amgen files first period 3 win for $400M dermatitis medicine

.Amgen has shared (PDF) the very first period 3 information on its own $400 thousand dermatitis medi...

Biogen, UCB file phase 3 lupus gain after stopping working earlier test

.Biogen and also UCB's rely on developing into phase 3 on the back of a failed research aims to have...

Aptadir hopes brand new RNA preventions may reverse complicated cancers

.Italian biotech Aptadir Therapeutics has actually launched along with the assurance that its own pi...

Wave surfs DMD excellence to regulators' doors, sending out stockpile

.Wave Life Sciences has actually satisfied its target in a Duchenne muscular dystrophy (DMD) researc...

Sanofi picks new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, occupy...

Achilles droplets cell treatment program, bandages for layoffs after missing out on 'commercial stability' objectives

.Achilles Rehabs has actually torn up its own technique. The English biotech is stopping work on its...

Aligos declares stage 2 MASH win, reducing liver body fat around 46%

.Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction associated steatohepatitis...

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job cultivating brand new antifungals has actually acquired a significant i...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Possessing presently gathered up the USA rights to Capricor Therapeutics' late-stage Duchenne muscu...